Unwanted interactions among psychotropic drugs and other treatments for autism spectrum disorders

TC Theoharides, S Asadi - Journal of clinical psychopharmacology, 2012 - journals.lww.com
Autism spectrum disorders (ASD) are pervasive neurodevelopmental disorders affecting
approx-imately 1% of children and characterized by varying degrees of deficiencies in social …

A case of prepubertal low-functioning autism with behavioral decompensation favorably responding to tianeptine

A Naguy, M Ali, DH Elsori, B Alamiri - Journal of Clinical …, 2019 - journals.lww.com
Autism spectrum disorder (ASD) is commonly coupled with a host of maladaptive
challenging behaviors. Pharmacotherapy is indicated once psychosocial and educational …

Psychopharmacology of autism spectrum disorders

G Kaplan, JT McCracken - Pediatric clinics, 2012 - pediatric.theclinics.com
(DSM-IV-TR), 1 ASDs are diagnosed in the presence of 3 core deficits:(1) impairment of
social interactions,(2) impaired communication, and (3) repetitive and stereotyped patterns …

16 PSYCHOPHARMACOLOGY OF AUTISM SPECTRUM DISORDER

JT McCracken, M Gandal - Autism spectrum disorder, 2016 - books.google.com
The use of a broad range of medications as a component of treatment for children and adults
with autism spectrum disorder (ASD) has become common clinical practice. Most surveys …

Psychopharmacology Management in Autism Spectrum Disorder

JA Salpekar, L Scahill - Pediatric Clinics, 2024 - pediatric.theclinics.com
Autism spectrum disorder (ASD; autism) is a heterogenous condition that varies in symptom
severity and is often accompanied by a range of behavioral problems. The common thread …

[HTML][HTML] Are there lessons to be learned from the prevailing patterns of psychotropic drug use in patients with autism spectrum disorder?

G Joshi - Acta Psychiatrica Scandinavica, 2017 - ncbi.nlm.nih.gov
Autism spectrum disorder (ASD) is a highly morbid neurodevelopmental disorder
characterized by varying degrees of deficits in social-emotional functioning along with …

Autism spectrum disorders-an emerging area in psychopharmacology

T Steckler, W Spooren, D Murphy - Psychopharmacology, 2014 - Springer
Autism spectrum disorder (ASD) is a high-cost, lifelong, neurodevelopmental condition
currently affecting up to 1 child in every 88 (CDC 2012) and about 1% of adults (Brugha et …

[HTML][HTML] Pediatric pharmacologic management of autism-associated behavioral dysregulation

W Xiong - American Journal of Psychiatry Residents' Journal, 2017 - Am Psychiatric Assoc
Autism spectrum disorder (ASD) is a developmental disorder characterized by persistent
impairments in social communication and interactions, in addition to restricted and repetitive …

Multiple antipsychotic medication use in autism spectrum disorder

LK Wink, EV Pedapati, PS Horn… - Journal of child and …, 2017 - liebertpub.com
Objective: The purpose of this study was to explore the use of multiple antipsychotic
medications in patients with autism spectrum disorder (ASD) by reviewing the longitudinal …

[HTML][HTML] Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world

SH Ameis, P Corbett-Dick, L Cole… - The Journal of clinical …, 2013 - psychiatrist.com
A utism spectrum disorder (ASD) is a diagnosis that is characterized by varying degrees of
(1) impairment in social reciprocity,(2) impairment in social communication, and (3) …